Form 8-K - Current report:
SEC Accession No. 0001558370-22-003560
Filing Date
2022-03-14
Accepted
2022-03-14 16:47:16
Documents
12
Period of Report
2022-03-10
Items
Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers

Document Format Files

Seq Description Document Type Size
1 8-K olma-20220310x8k.htm   iXBRL 8-K 33876
  Complete submission text file 0001558370-22-003560.txt   152786

Data Files

Seq Description Document Type Size
2 EX-101.SCH olma-20220310.xsd EX-101.SCH 3037
3 EX-101.LAB olma-20220310_lab.xml EX-101.LAB 15933
4 EX-101.PRE olma-20220310_pre.xml EX-101.PRE 10058
6 EXTRACTED XBRL INSTANCE DOCUMENT olma-20220310x8k_htm.xml XML 4867
Mailing Address 512 2ND STREET, 4TH FLOOR SAN FRANCISCO CA 94107
Business Address 512 2ND STREET, 4TH FLOOR SAN FRANCISCO CA 94107 (415) 651-3316
Olema Pharmaceuticals, Inc. (Filer) CIK: 0001750284 (see all company filings)

EIN.: 300409740 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-39712 | Film No.: 22737233
SIC: 2834 Pharmaceutical Preparations